Inspection Record

McNeil Healthcare, LLC — FDA 483 Findings

US FDAInspected 2015-07-24Published 2024-01-17 7 findingsLaboratory and QC controlsDeviation, CAPA, and investigationComplaint and recall handlingEquipment and facilityQuality unit oversight

Inspectors Jose R Lopez · Raquel Gonzalez RiveraThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Laboratory and QC controls

Laboratory records do not include complete data derived from all tests, examinations and assay necessary to assure compliance with established specifications and standards.

2Deviation, CAPA, and investigation

Investigations of an unexplained discrepancy did not extend to other batches of the same drug product and other drug products that may have been associated with the specific failure or discrepancy.

3Deviation, CAPA, and investigation

There is a failure to thoroughly review any unexplained discrepancy whether or not the batch has been already distributed.

4Complaint and recall handling

An NDA-Field Alert Report was not submitted within three working days of receipt of information concerning bacteriological contamination and significant chemical, physical, or other change or deterioration in a distributed drug product.

5Laboratory and QC controls

Laboratory controls do not include the establishment of scientifically sound and appropriate specifications, standards, and test procedures designed to assure that drug products conform to appropriate standards of identity, strength, quality and purity.

6Equipment and facility

Written procedures are not followed for the cleaning and maintenance of equipment, including utensils, used in the manufacture, processing, packing or holding of a drug product.

7Quality unit oversight

The responsibilities and procedures applicable to the quality control unit are not in writing and fully followed.

About this record

Extracted automatically from the document US FDA published on 2024-01-17. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

McNeil Healthcare, LLC company profile — full history US FDA documents, 2024 Go to Findings search